On the other hand, since the plasma tau protein was detected around 3 months after stroke in our study, its concentration might be more related to either pre-existing or stroke-related neurodegeneration, rather than the direct neuronal injury effect (Chen and Jiang, 2019). The gene discussed is MAPT; the disease is Stroke.